Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,348,708
-
Share change
-
-2,741,588
-
Total reported value
-
$218,818,451
-
Put/Call ratio
-
260%
-
Price per share
-
$10.25
-
Number of holders
-
92
-
Value change
-
-$30,727,481
-
Number of buys
-
42
-
Number of sells
-
50
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q2 2014
As of 30 Jun 2014 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,348,708 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, WELLS FARGO & COMPANY/MN, BlackRock Fund Advisors, DRIEHAUS CAPITAL MANAGEMENT LLC, FRANKLIN RESOURCES INC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Foresite Capital Management I, LLC, VANGUARD GROUP INC, Cormorant Asset Management, LLC, and FMR LLC.
This table shows 92 institutional shareholders of the security as of 30 Jun 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.